Partner Content Partner Content Calling all Microbiologists - 5 great reasons to be in San D... Pharmaceutical Microbiology West Coast Conference 2018
News FDA knocks back Zealand's dasiglucagon once again Zealand Pharma has suffered another setback in its bid to bring glucagon receptor agonist dasiglucagon for ultra-rare disease congenital hyperinsulinism (CHI) to the US market.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
